Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alex Magno Coelho Horimoto, Cintia Zumstein Camargo & Cristiane Kayser. (2019) Less severe disease in patients with early systemic sclerosis?. Modern Rheumatology 29:6, pages 977-983.
Read now
Read now
Articles from other publishers (11)
Alice Cole, Voon H. Ong & Christopher P. Denton. (2022) Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis. Clinical Reviews in Allergy & Immunology 64:3, pages 378-391.
Crossref
Crossref
Chiara Pellicano, Marzia Miglionico, Laura Romaggioli, Amalia Colalillo, Lorenzo Vantaggio, Cecilia Napodano, Cinzia Callà, Francesca Gulli, Mariapaola Marino, Umberto Basile & Edoardo Rosato. (2022) Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis. Journal of Personalized Medicine 12:2, pages 284.
Crossref
Crossref
Silvia Cavalli, Paola Adele Lonati, Maria Gerosa, Roberto Caporali, Rolando Cimaz & Cecilia Beatrice Chighizola. (2022) Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases. Frontiers in Pharmacology 13.
Crossref
Crossref
Michael Osthoff, Veronika K. Jaeger, Ingmar A. F. M. Heijnen, Marten Trendelenburg, Suzana Jordan, Oliver Distler & Ulrich A. Walker. (2019) Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study. Arthritis Research & Therapy 21:1.
Crossref
Crossref
Hiroyuki Yamashita, Ryosuke Kamei & Hiroshi Kaneko. (2019) Classifications of scleroderma renal crisis and reconsideration of its pathophysiology. Rheumatology 58:12, pages 2099-2106.
Crossref
Crossref
Gabriele Valentini, Michele Iudici, Ulrich A Walker, Veronika K Jaeger, Murray Baron, Patricia Carreira, László Czirják, Christopher P Denton, Oliver Distler, Eric Hachulla, Ariane L Herrick, Otylia Kowal-Bielecka, Janet Pope, Ulf Müller-Ladner, Gabriela Riemekasten, Jerome Avouac, Marc Frerix, Suzana Jordan, Tünde Minier, Elise Siegert, Voon H Ong, Serena Vettori & Yannick Allanore. (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Annals of the Rheumatic Diseases 76:1, pages 270-276.
Crossref
Crossref
Monique Hinchcliff & Michael L. Whitfield. 2017. Scleroderma. Scleroderma
657
670
.
Christie P. Thomas, Carla M. Nester, Andrew C. Phan, Manisha Sharma, Amanda L. Steele & Petar S. Lenert. (2015) Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome. Clinical Kidney Journal 8:6, pages 698-701.
Crossref
Crossref
Michael Osthoff, Gene-Siew Ngian, Melinda M Dean, Mandana Nikpour, Wendy Stevens, Susanna Proudman, Damon P Eisen & Joanne Sahhar. (2014) Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study. Arthritis Research & Therapy 16:6.
Crossref
Crossref
Ulf Müller-Ladner, Alan Tyndall, Laszlo Czirjak, Christopher Denton & Marco Matucci-Cerinic. (2014) Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?. Annals of the Rheumatic Diseases 73:2, pages 324-327.
Crossref
Crossref
Christie P. Thomas, Carla M. Nester, Andrew C. Phan, Manisha Sharma, Amanda L. Steele & Petar S. Lenert. (2016) Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome. Proceedings of the Royal Society of Medicine 7:Sect_Psych, pages 698-701.
Crossref
Crossref